22

Developing mHealth with a foot in two shoes

  • Upload
    3gdr

  • View
    71

  • Download
    1

Embed Size (px)

Citation preview

Page 1: Developing mHealth with a foot in two shoes
Page 2: Developing mHealth with a foot in two shoes

Optimising Oncology Outcomes

Patient'Experience''

P✗ Dr. Anne Bruinvels

Founder, Px HealthCare

European Cancer Patient Coalition Unleashing mHealth!

25 May 2016

Page 3: Developing mHealth with a foot in two shoes

P✗ tackling cancer

Prime developer of validated, mobile Patient Empowerment tools in oncology, uniquely combined with…

Apps which have demonstrated to improve the patient – physician relat ionship

Advanced data-analyt ics to large-scale data providing insights into the effectiveness of treatments

1| 2|

the use of anonymised, real-time Patient Reported Outcome data to improve clinical outcomes

Page 4: Developing mHealth with a foot in two shoes

Founded by medical scientists, Amsterdam (2012)

Previously founded & exited a biotech, data-mining company

(Curidium, through listing on LSE)

Strong scientific & entrepreneurial track record

Developed an innovative, award-winning, patient-experience & data-

analysis platform in oncology  (OWise)

about P✗

Px HealthCare takes first place in J&J Digital Health Masterclass

London, 21.11.2013

Page 5: Developing mHealth with a foot in two shoes

personalised treatment information

all personal information in 1 place

tools improving patient experience

patient better informed & more at ease

features & benefits

Page 6: Developing mHealth with a foot in two shoes

track & share data on well-being

better insight in to situation

advanced privacy & security

improves patient-doctor dialogue

features & benefits

Page 7: Developing mHealth with a foot in two shoes

“The OWise patient appears to deal with her emotional issues much earlier in the process”, breast cancer surgeon, UMC Utrecht

“I can now explain much better to my doctors how I have been feeling in between hospital visits”, Yve, 41 years

“Glad to use the OWise app. So good that it exists”, Tineke, 50 years (wrote this 7 days following lumpectomy)

90% 90%

Pilotstudie UMC Utrecht, D. Afat-Young et al. 2014: European Breast Cancer Conference

appreciated by patients & doctors

Page 8: Developing mHealth with a foot in two shoes

D. Young-Afat et al. 2014: Poster 181: UMC Utrecht, European Breast Cancer Conference

results from independent pilot study on OWise

Page 9: Developing mHealth with a foot in two shoes

OWise awards & certificates P✗ awards & OWise certificates

Marked!!Since!May!2014!

Winner 2014

Top Prize Supported by:

Innovation Fellow

Page 10: Developing mHealth with a foot in two shoes

no cost for patient

Page 11: Developing mHealth with a foot in two shoes

improved treatment efficacy & safety

improved health outcomes

advanced data-analytics

identifying correlations & trends

treatment efficacy & safetydrug-drug interactions

Insights from large-scale Patient-Reported-Outcome data

patient subgroups

treatment effects

disease prognosis

real-time patient health data

patient population data

Page 12: Developing mHealth with a foot in two shoes

new breast cancer cases/ year

UK: 50K NL: 14K>2.5K users

Innovation FellowintroducedFeb‘16  

live sinceApr ‘13

Page 13: Developing mHealth with a foot in two shoes

all other cancers to be launched in EU & US 2017

b r e a s t c a n c e r

launched in UKFeb 2016

2.0

to be developed & launched in 2016/7

OWise development

Page 14: Developing mHealth with a foot in two shoes
Page 15: Developing mHealth with a foot in two shoes

w w w. o w i s e . u k

Page 16: Developing mHealth with a foot in two shoes
Page 17: Developing mHealth with a foot in two shoes
Page 18: Developing mHealth with a foot in two shoes
Page 19: Developing mHealth with a foot in two shoes
Page 20: Developing mHealth with a foot in two shoes
Page 21: Developing mHealth with a foot in two shoes

Innovation Fellow

 or  go  to  www.owise.uk  

Page 22: Developing mHealth with a foot in two shoes

www.owise.uk or please contactAnne Bruinvels,

T: +44 77 6780 7865

E: [email protected]

Patient'Experience''Optimising'Oncology'Outcomes'

P✗